XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

166 hedge funds and large institutions have $1.97B invested in Acceleron Pharma in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.8M
Puts
$6.14M
Net Calls
Net Calls Change

Top Buyers

1 +$15.2M
2 +$11.4M
3 +$9.9M
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$7.98M
5
Citadel Advisors
Citadel Advisors
Florida
+$7.25M

Top Sellers

1 -$37.7M
2 -$29.6M
3 -$13.3M
4
Franklin Resources
Franklin Resources
California
-$12.5M
5
State Street
State Street
Massachusetts
-$12.1M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$4.51M
52
$4.29M
53
$3.85M
54
$3.77M
55
$3.62M
56
$3.45M
57
$3.44M
58
$3.39M
59
$3.36M
60
$3.17M
61
$3M
62
$2.88M
63
$2.87M
64
$2.85M
65
$2.77M
66
$2.77M
67
$2.69M
68
$2.67M
69
$2.6M
70
$2.56M
71
$2.45M
72
$2.44M
73
$2.26M
74
$2.19M
75
$2.17M